Finding the target after screening the phenotype

Drug Discovery Today

Volumn 10, Issue 7, 2005, Pages 513-519

  Hart, Charles P ^a  

^a Galileo Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOTIN; CAPSAICIN; COLCHICINE; CYCLOSPORIN; CYTOCHALASIN B; DOXORUBICIN; E 3330; FUMAGILLIN; GELDANAMYCIN; HMN 154; LAF 389; NICOTINIC ACID; PNRI 299; PURVALANOL B; RADICICOL; STREPTAVIDIN; TACROLIMUS; TRICHOSTATIN A; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANTINEOPLASTIC ACTIVITY; CELL CYCLE; DNA BINDING; DNA LIBRARY; DNA MICROARRAY; DRUG ACTIVITY; DRUG ISOLATION; DRUG TARGETING; GENE EXPRESSION; GENOME; IMMUNOSUPPRESSIVE TREATMENT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVOUS SYSTEM DEVELOPMENT; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEOMICS; REVIEW;

ANIMALS; CHROMATOGRAPHY, AFFINITY; DRUG DESIGN; GENE EXPRESSION PROFILING; GENE LIBRARY; GENOME; HUMANS; PHARMACEUTICAL PREPARATIONS; PHENOTYPE; PROTEIN ARRAY ANALYSIS; PROTEINS; PROTEOMICS; SYSTEMS BIOLOGY;

EID: 17044373269     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03415-X     Document Type: Review

References (53)

1. Clemons P.A. Complex phenotypic assays in high-throughput screening. Curr. Opin. Chem. Biol. 8:2004;334-338
2. Peterson J.R., Mitchison T.J. Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem. Biol. 9:2002;1275-1285
3. Lokey R.S. Forward chemical genetics: progress and obstacles on the path to a new pharmacopoeia. Curr. Opin. Chem. Biol. 7:2003;91-96
4. Wignall S.M., et al. Identification of a novel protein regulating microtubule stability through a chemical approach. Chem. Biol. 11:2004;135-146
5. Ki S.W., et al. Radiciol binds and inhibits mammalian ATP citrate lyase. J. Biol. Chem. 275:2000;39231-39236
6. Shimizu N., et al. High performance affinity beads for identifying drug receptors. Nat. Biotechnol. 18:2000;877-881
7. Khersonsky S.M., et al. Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J. Am. Chem. Soc. 125:2003;11804-11805
8. Tanaka H., et al. Isolation of cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure: drug-western. Mol. Pharmacol. 55:1999;356-363
9. Sche P.P., et al. Display cloning: functional identification of natural product receptors using cDNA-phage display. Chem. Biol. 6:1999;707-716
10. Savinov S.N., Austin D.J. The cloning of human genes using cDNA phage display and small-molecule chemical probes. Comb. Chem. High Throughput Screen. 4:2001;593-597
11. Jin Y., et al. Identification of hNopp140 as a binding partner for doxorubicin with a phage display cloning method. Chem. Biol. 9:2002;157-162
12. Mattheakis L.C., et al. An in vitro polysome display system for identifying ligands from very large peptide libraries. Proc. Natl. Acad. Sci. U.S.A. 91:1994;9022-9026
13. McPherson M., et al. Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. Chem. Biol. 9:2002;691-698
14. Licitra E.J., Liu J.O. A three-hybrid system for detecting small-ligand-protein receptor interactions. Proc. Natl. Acad. Sci. U.S.A. 93:1996;12817-12821
15. Becker F., et al. A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors. Chem. Biol. 11:2004;211-223
16. Kley N. Chemical dimerizers and three-hybrid systems: scanning the proteome for targets of organic small molecules. Chem. Biol. 11:2004;599-608
17. Baker K., et al. An optimized dexamethasone-methotrexate yeast 3-hybrid system for high throughput screening of small molecule-protein interactions. Anal. Biochem. 315:2003;134-137
18. Jona G., Snyder M. Recent developments in analytical and functional protein microarrays. Curr. Opin. Mol. Ther. 5:2003;271-277
19. MacBeath G., Schreiber S. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763
20. Ziauddin J., Sabatini D.M. Microarrays of cells expressing defined cDNAs. Nature. 411:2001;107-110
21. Bredel M., Jacoby E. Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat. Rev. Genet. 5:2004;262-275
22. Zheng X.S., et al. Genetic and genomic approaches to identify and study the targets of bioactive small molecules. Chem. Biol. 11:2004;609-618
23. Scherf U., et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24:2000;236-244
24. Browne L.J., et al. Chemogenomics-pharmacology with genomics tools. Targets. 1:2002;59-65
25. Gould-Rothberg B.E., et al. The characterization of PPAR alpha ligand drug action in an in vivo model by comprehensive differential gene expression profiling. Funct. Integr. Genomics. 1:2001;294-304
26. Haggarty S.J., et al. Chemical genomic profiling of biological networks using graph theory and combinations of small molecule perturbations. J. Am. Chem. Soc. 125:2003;10543-10545
27. Towbin H., et al. Proteomics-based target identification Bengamides as a new class of methionine aminopeptidase inhibitors. J. Biol. Chem. 278:2003;52964-52971
28. Plavec I., et al. Method for analyzing signaling networks in complex cellular systems. Proc. Natl. Acad. Sci. U.S.A. 101:2004;1223-1228
29. Kunkel E.J., et al. An integrative biology approach for analysis of drug action in models of human vascular inflammation. FASEB J. 18:2004;1279-1281
30. Watkins S.M., German J.B. Metabolomics and biochemical profiling in drug discovery and development. Curr. Opin. Mol. Ther. 4:2002;224-228
31. Watkins S.M., et al. Lipid metabolome-wide effects of the PPARg agonist rosiglitazone. J. Lipid Res. 43:2002;1809-1817
32. Perlman Z., et al. Multidimensional drug profiling by automated microscopy. Science. 306:2004;1194-1198
33. Kiger A.A., et al. A functional genomic analysis of cell morphology using RNA interference. J. Biol. 2:2003;27
34. Conrad C., et al. Automatic identification of subcellular phenotypes on human cell arrays. Genome Res. 14:2004;1130-1136
35. Heitman J., et al. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 253:1991;905-909
36. Parsons A.B., et al. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nat. Biotechnol. 22:2004;62-69
37. Giaever G., et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature. 418:2002;387-391
38. Giaever G., et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. U.S.A. 101:2004;793-798
39. Lum P.Y., et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygtes. Cell. 116:2004;121-137
40. Marton M.J., et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4:1998;1293-1301
41. Carpenter A.E., Sabatini D.M. Systematic genome-wide screens of gene function. Nat. Rev. Genet. 5:2004;11-22
42. Harding M.W., et al. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 341:1989;758-760
43. Yoshida M., et al. potent and selective inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265:1990;17174-17179
44. Whitesell L., et al. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8324-8328
45. Sin N., et al. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6099-6103
46. Caterina M.J., et al. The capsaicin receptor; a heat-activated ion channel in the pain pathway. Nature. 389:1997;816-824
47. Meng L., et al. Eponemycin exerts its antitumor effect through the inhibition of proteosome function. Cancer Res. 59:1999;2798-2801
48. Mayer T.U., et al. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science. 286:1999;971-974
49. Knockert M., et al. Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilized inhibitors. Chem. Biol. 7:2000;411-422
50. Peterson J.R., et al. A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. Proc. Natl. Acad. Sci. U.S.A. 98:2001;10624-10629
51. Tunaro S., et al. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat. Med. 9:2003;352-355
52. Ding S., et al. Synthetic small molecules that control stem cell fate. Proc. Natl. Acad. Sci. U.S.A. 100:2003;7632-7637
53. Nguyen C., et al. Chemogenomic identification of Ref-1/AP-1 as a therapeutic target for asthma. Proc. Natl. Acad. Sci. U.S.A. 100:2003;1169-1173